Related references
Note: Only part of the references are listed.High-throughput miRNA profiling of human melanoma blood samples
Petra Leidinger et al.
BMC CANCER (2010)
miRNAs in lung cancer - Studying complex fingerprints in patient's blood cells by microarray experiments
Andreas Keller et al.
BMC CANCER (2009)
An Outlook on Ovarian Cancer and Borderline Ovarian Tumors: Focus on Genomic and Proteomic Findings
Andrea Tinelli et al.
CURRENT GENOMICS (2009)
Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
Usha Menon et al.
LANCET ONCOLOGY (2009)
Screening for Ovarian Cancer
Daniel L. Clarke-Pearson
NEW ENGLAND JOURNAL OF MEDICINE (2009)
miR2Disease: a manually curated database for microRNA deregulation in human disease
Qinghua Jiang et al.
NUCLEIC ACIDS RESEARCH (2009)
Ovarian Cancer To Screen or Not to Screen
David G. Mutch
OBSTETRICS AND GYNECOLOGY (2009)
Results From Four Rounds of Ovarian Cancer Screening in a Randomized Trial
Edward Partridge et al.
OBSTETRICS AND GYNECOLOGY (2009)
Detection of Cancer with Serum miRNAs on an Oligonucleotide Microarray
Michael J. Lodes et al.
PLOS ONE (2009)
Multiple Sclerosis: MicroRNA Expression Profiles Accurately Differentiate Patients with Relapsing-Remitting Disease from Healthy Controls
Andreas Keller et al.
PLOS ONE (2009)
The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions
A. C. Antoniou et al.
BRITISH JOURNAL OF CANCER (2008)
Overexpression of Interleukin-1β Induces Gastric Inflammation and Cancer and Mobilizes Myeloid-Derived Suppressor Cells in Mice
Shuiping Tu et al.
CANCER CELL (2008)
MicroRNA expression profiling in human ovarian cancer:: miR-214 induces cell survival and cisplatin resistance by targeting PTEN
Hua Yang et al.
CANCER RESEARCH (2008)
Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases
Xi Chen et al.
CELL RESEARCH (2008)
Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells
Ilaria Marigo et al.
IMMUNOLOGICAL REVIEWS (2008)
Quantitation of circulating tumor cells in blood samples from ovarian and prostate cancer patients using tumor-specific fluorescent ligands
Wei He et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
MicroRNAs accurately identify cancer tissue origin
Nitzan Rosenfeld et al.
NATURE BIOTECHNOLOGY (2008)
Microfluidic-based enzymatic on-chip labeling of miRNAs
Sonia Vorwerk et al.
NEW BIOTECHNOLOGY (2008)
Serum MicroRNAs Are Promising Novel Biomarkers
Shlomit Gilad et al.
PLOS ONE (2008)
An Analysis of Human MicroRNA and Disease Associations
Ming Lu et al.
PLOS ONE (2008)
Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer
Lin Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies
Martin Koebel et al.
PLOS MEDICINE (2008)
miRBase: tools for microRNA genomics
Sam Griffiths-Jones et al.
NUCLEIC ACIDS RESEARCH (2008)
microRNAs as oncogenes and tumor suppressors
Baohong Zhang et al.
DEVELOPMENTAL BIOLOGY (2007)
Early detection of ovarian cancer
Donna Badgwell et al.
DISEASE MARKERS (2007)
A minimally invasive multiple marker approach allows highly efficient detection of meningioma tumors
Andreas Keller et al.
BMC BIOINFORMATICS (2006)
MicroRNA signatures in human cancers
George A. Calin et al.
NATURE REVIEWS CANCER (2006)
Maintenance or consolidation therapy in advanced ovarian cancer
D. Pectasides et al.
ONCOLOGY (2006)
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
RN Kaplan et al.
NATURE (2005)
CA125 in ovarian cancer: European Group on Tumor Markers guidelines for clinical use
MJ Duffy et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2005)
Rfam: annotating non-coding RNAs in complete genomes
S Griffiths-Jones et al.
NUCLEIC ACIDS RESEARCH (2005)
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
TJ Curiel et al.
NATURE MEDICINE (2004)
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history:: A combined analysis of 22 studies
A Antoniou et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
Controlling the false discovery rate in behavior genetics research
Y Benjamini et al.
BEHAVIOURAL BRAIN RESEARCH (2001)
Share Paper
